These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 25862857

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in a BRAF(V600E) Mutation-Prevalent Area.
    Jeon MJ, Chun SM, Kim D, Kwon H, Jang EK, Kim TY, Kim WB, Shong YK, Jang SJ, Song DE, Kim WG.
    Thyroid; 2016 May; 26(5):683-90. PubMed ID: 26980298
    [Abstract] [Full Text] [Related]

  • 4. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.
    Teng L, Deng W, Lu J, Zhang J, Ren X, Duan H, Chuai S, Duan F, Gao W, Lu T, Wu H, Liang Z.
    Oncotarget; 2017 Mar 28; 8(13):22023-22033. PubMed ID: 28423545
    [Abstract] [Full Text] [Related]

  • 5. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
    Bonhomme B, Godbert Y, Perot G, Al Ghuzlan A, Bardet S, Belleannée G, Crinière L, Do Cao C, Fouilloux G, Guyetant S, Kelly A, Leboulleux S, Buffet C, Leteurtre E, Michels JJ, Tissier F, Toubert ME, Wassef M, Pinard C, Hostein I, Soubeyran I.
    Thyroid; 2017 May 28; 27(5):682-692. PubMed ID: 28351340
    [Abstract] [Full Text] [Related]

  • 6. Genomic Landscape of poorly Differentiated and Anaplastic Thyroid Carcinoma.
    Xu B, Ghossein R.
    Endocr Pathol; 2016 Sep 28; 27(3):205-12. PubMed ID: 27372303
    [Abstract] [Full Text] [Related]

  • 7. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
    Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA.
    J Clin Invest; 2016 Mar 01; 126(3):1052-66. PubMed ID: 26878173
    [Abstract] [Full Text] [Related]

  • 8. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
    Pita JM, Figueiredo IF, Moura MM, Leite V, Cavaco BM.
    J Clin Endocrinol Metab; 2014 Mar 01; 99(3):E497-507. PubMed ID: 24423316
    [Abstract] [Full Text] [Related]

  • 9. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
    Latteyer S, Tiedje V, König K, Ting S, Heukamp LC, Meder L, Schmid KW, Führer D, Moeller LC.
    Endocrine; 2016 Dec 01; 54(3):733-741. PubMed ID: 27696251
    [Abstract] [Full Text] [Related]

  • 10. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
    Santarpia L, El-Naggar AK, Cote GJ, Myers JN, Sherman SI.
    J Clin Endocrinol Metab; 2008 Jan 01; 93(1):278-84. PubMed ID: 17989125
    [Abstract] [Full Text] [Related]

  • 11. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.
    Sandulache VC, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cote GJ, Singh RR, Luthra R, Cabanillas ME.
    Thyroid; 2017 Jan 01; 27(1):81-87. PubMed ID: 27785980
    [Abstract] [Full Text] [Related]

  • 12. A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer.
    Romei C, Elisei R.
    Int J Mol Sci; 2021 Feb 09; 22(4):. PubMed ID: 33572167
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
    Kunstman JW, Juhlin CC, Goh G, Brown TC, Stenman A, Healy JM, Rubinstein JC, Choi M, Kiss N, Nelson-Williams C, Mane S, Rimm DL, Prasad ML, Höög A, Zedenius J, Larsson C, Korah R, Lifton RP, Carling T.
    Hum Mol Genet; 2015 Apr 15; 24(8):2318-29. PubMed ID: 25576899
    [Abstract] [Full Text] [Related]

  • 14. Activating BRAF and PIK3CA mutations cooperate to promote anaplastic thyroid carcinogenesis.
    Charles RP, Silva J, Iezza G, Phillips WA, McMahon M.
    Mol Cancer Res; 2014 Jul 15; 12(7):979-86. PubMed ID: 24770869
    [Abstract] [Full Text] [Related]

  • 15. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R.
    Thyroid; 2020 Oct 15; 30(10):1505-1517. PubMed ID: 32284020
    [Abstract] [Full Text] [Related]

  • 16. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo M, Williams MD, Ferrarotto R, Gunn GB, Wei P, Patel K, Hofmann MC, Cabanillas ME.
    Thyroid; 2021 Aug 15; 31(8):1235-1243. PubMed ID: 33599171
    [Abstract] [Full Text] [Related]

  • 17. Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects.
    Ibrahimpasic T, Ghossein R, Shah JP, Ganly I.
    Thyroid; 2019 Mar 15; 29(3):311-321. PubMed ID: 30747050
    [Abstract] [Full Text] [Related]

  • 18. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
    Chen H, Luthra R, Routbort MJ, Patel KP, Cabanillas ME, Broaddus RR, Williams MD.
    Mol Cancer Ther; 2018 Jul 15; 17(7):1575-1584. PubMed ID: 29695638
    [Abstract] [Full Text] [Related]

  • 19. Genomic Profiling of Aggressive Thyroid Cancer in Association With its Clinicopathological Characteristics.
    Kim JH, Jeong JY, Seo AN, Park NJ, Kim M, Park JY.
    In Vivo; 2022 Jul 15; 36(1):111-120. PubMed ID: 34972706
    [Abstract] [Full Text] [Related]

  • 20. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Nikitski AV, Rominski SL, Condello V, Kaya C, Wankhede M, Panebianco F, Yang H, Altschuler DL, Nikiforov YE.
    Thyroid; 2019 Oct 15; 29(10):1425-1437. PubMed ID: 31298630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.